Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Equity Ratio (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Equity Ratio readings, the most recent being 0.46 for Q4 2025.

  • On a quarterly basis, Equity Ratio fell 11.88% to 0.46 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.46, a 11.88% decrease, with the full-year FY2025 number at 0.46, down 11.88% from a year prior.
  • Equity Ratio hit 0.46 in Q4 2025 for Treace Medical Concepts, up from 0.45 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.72 in Q2 2021 to a low of 0.02 in Q1 2021.
  • Median Equity Ratio over the past 5 years was 0.52 (2024), compared with a mean of 0.51.
  • Biggest five-year swings in Equity Ratio: skyrocketed 3460.77% in 2021 and later crashed 43.82% in 2022.
  • Treace Medical Concepts' Equity Ratio stood at 0.66 in 2021, then tumbled by 42.41% to 0.38 in 2022, then surged by 43.86% to 0.55 in 2023, then decreased by 5.03% to 0.52 in 2024, then dropped by 11.88% to 0.46 in 2025.
  • The last three reported values for Equity Ratio were 0.46 (Q4 2025), 0.45 (Q3 2025), and 0.47 (Q2 2025) per Business Quant data.